Human bone marrow adipocytes support dexamethasone-induced osteoclast differentiation and function through RANKL expression
スポンサーリンク
概要
- 論文の詳細を見る
The TNF-family molecule, Receptor Activator of Nuclear factor κ B Ligand (RANKL) is known as a key regulator for bone remodeling, and is essential for the development and activation of osteoclasts. In this study, we examined the regulation of RANKL in primary human bone marrow adipocytes and the relationship between bone marrow adipocytes and bone metabolism. RANKL expression and the RANKL/osteoprotegerin (OPG) mRNA ratio in marrow adipocytes increased following dexamethasone treatment. In co-cultures of human osteoclast precursors and bone marrow adipocytes with dexamethasone, osteoclast precursors differentiated to TRAP-positive multi-nuclear cells. Moreover, the ability of bone resorption was confirmed in co-culture in flasks coated with calcium phosphate film. Osteoclast precursor differentiation and bone resorption were blocked by RANKL antibody pretreatment. TRAP-positive multinuclear cells did not form in co-culture without cell-to-cell contact conditions. We conclude that primary human bone marrow adi-pocytes have the ability to promote osteoclast differentiation and activities, similar to osteoblasts and other RANKL-expressing cells.
論文 | ランダム
- HTLV-I抗体陰性, pX遺伝子のみ認められたT細胞白血病の一症例
- CD4分子の異常 -OKT4エピトープ欠損(症)-
- 447 Prostaglandin E (PGE) の好酸球反応とIgE 産生に及ぼす影響について
- 290.子宮頚部glassy cell carcinomaの1例(婦人科14:子宮頸部II, 示説, 第27回日本臨床細胞学会秋期大会学術集会)
- 222.子宮内膜serous adenocarcinomaの1例(婦人科9:子宮体部III, 示説, 第27回日本臨床細胞学会秋期大会学術集会)